Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
RITUXIMAB-HYALURONIDASE HUMAN 1600-26800 MG -UT/13.4ML SC SOLN (NDC 50242010901) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 9, 2026 , from http://ppman.hank.ai/transparency/procedure/50242010901/by-state?code_type=NDC
“RITUXIMAB-HYALURONIDASE HUMAN 1600-26800 MG -UT/13.4ML SC SOLN (NDC 50242010901) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/50242010901/by-state?code_type=NDC. Accessed
November 9, 2026 .
“RITUXIMAB-HYALURONIDASE HUMAN 1600-26800 MG -UT/13.4ML SC SOLN (NDC 50242010901) by State,” HANK Price Transparency ,
accessed November 9, 2026 ,
http://ppman.hank.ai/transparency/procedure/50242010901/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
50242010901 — Rituximab-hyaluronidase Human 1600-26800 Mg -ut/13.4ml Sc Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$13,039
National median
$6,286 – $14,375
IQR (p25 – p75)
11
hospitals filing
4
states
Walking in without insurance?
Cash / self-pay price
Cash median
$10,541
vs. negotiated
-19.2%
Hospitals reporting
18
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 50242010901 (NDC), with interquartile range
State Median p25 p75
MO $31,004 $12,691 $33,071
CA $13,416 $9,679 $14,375
MI $12,124 $9,740 $15,141
NJ $2 $2 $22,514